Gilead Shares Early Results Of Remdesivir Trial In COVID-19 Patients
3 years ago
346
Sci/Health
coronavirus
U.S.
covid-19
remdesivir
patients
study
gilead
gildead sciences
symptoms
standard care
Patients given remdesivir for five days had improved symptoms compared to those who were only given standard care.
Loading 1 comment...
-
2:07
Newsy
1 year agoPresident Biden's visit to Ukraine required careful, quiet planning
2.21K5 -
1:01
Newsy
3 years agoTrial Finds Remdesivir As Beneficial COVID-19 Drug, NIH Says
9752 -
0:24
KJRH
4 years agoOU Medicine Announces New Clinical Trial to Treat COVID-19 Patients
37 -
0:27
KTNV
3 years agoHeartburn drug could help COVID-19 patients
232 -
2:28
KMTV
4 years agoWoman shares experience with COVID-19
763 -
2:09
WMAR
3 years agoApp identifies symptoms, helps patients seek COVID-19 treatment
129 -
0:30
KTNV
4 years agoRobot dog helps COVID-19 patients communicate
5281 -
2:06
KSHB
4 years agoTesting cancer patients for COVID-19
248 -
3:23
WCPO
3 years agoPatients delaying care due to COVID-19
12 -
2:45
KTNV
4 years agoUMC using hydroxychloroquine for COVID-19 patients
1.53K2